To evaluate the association between biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) use and quality of life (QoL) in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and
The Data wasLived Experience of Patients with End-Stage Renal Disease, Receiving Hemodialysis at Zewuditu Memorial Hospital, Addis Ababa Ethiopia. a Qualitative Study
Sickle cell disease (SCD) is a lifelong blood disorder affecting approximately 100,000 individuals in the United States (US). A number of new treatments have recently become available to improve SCD c
